Neil Dahiya

Roche has announced that their supplemental Biologics License Application (sBLA) for Columvi (glofitamab), when used in combination with gemcitabine and oxaliplatin (GemOx), has been accepted by the US Food and Drug Administration (FDA). This combination is intended for patients suffering […]

GSK plc has disclosed a new agreement with Chongqing Zhifei Biological Products, Ltd. (Zhifei) to modify the existing arrangement for Zhifei’s commercialisation of GSK’s Shingrix shingles vaccine within mainland China. This amended pact lengthens the initial 3-year timespan (2024-2026) granting

The United States Food and Drug Administration (FDA) has approved AstraZeneca’s Imfinzi (durvalumab) for adult patients diagnosed with limited-stage small cell lung cancer (LS-SCLC) whose disease remains stable following a regimen of concurrent platinum-based chemotherapy and radiotherapy. The FDA’s decision

The All India Drugs Control Officers’ Confederation (AIDCOC), representing the nation’s drug control officers, has expressed its alarm regarding the suspension of Karnataka’s state drugs controller. This action followed the deaths of four pregnant women from complications allegedly linked to

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) is partnering with Ernst & Young (EY) to craft an all-encompassing Sectoral Manual focused on Drugs and Pharmaceutical Exports — aligning with Product Market Fit. This project seeks to offer significant insights

Development is actively underway for the planned pharmaceutical hub in Karasur, Pondicherry. The local drug manufacturers’ body, PDMA, has approached the government with a proposal asserting that 50 pharma companies in the region are prepared to back the project financially.

Advanced diagnostics, genomic testing, and mobile health technologies are revolutionizing the way healthcare is delivered, especially in rural and underserved regions. These advancements promise to reduce healthcare costs and enhance health management for communities that are challenging to reach. Dinesh

The Union Ministry of Health and Family Welfare has reestablished the Central Expert Panel to assess the appropriate compensation for patients fitted with defective Articular Surface Replacement (ASR) hip implants, originally manufactured by DePuy International Limited, UK, now operating as

Vaxcyte Inc, a pioneering company at the forefront of vaccine development, has revealed the commencement of its phase 2 trial for VAX-31 in healthy infants. This marks an important milestone as the first participants have received their initial doses. The

Neuranics, a trailblazer in healthcare diagnostics, has garnered $700,000 in seed funding, predominantly supported by Inflection Point Ventures (IPV). These resources are earmarked for advancing their technological capabilities and clinical validations, propelling the startup on its journey to transform blood